Helsinki, 12 December 2014 at 5:00 pm
Nexstim Plc will publish the following financial information in 2015:
* The 2014 Financial Statements Bulletin and Half-Yearly Report July-December
2014 (H2) on Thursday, February 26, 2015
* Half-Yearly Report January-June 2015 (H1) on Thursday, August 20, 2015
Nexstim Annual Report 2014 will be published on company web pages on Monday,
March 9, 2015.
The Annual General Meeting is tentatively scheduled to be held on Tuesday, March
31, 2015 at 9:00 a.m.
NEXSTIM PLC
Board of Directors
For further information please visit www.nexstim.com or contact:
Nexstim 040 8615046
Janne Huhtala, Chief Executive Officer janne.huhtala@nexstim.com
UB Capital Oy (Certified Adviser) 09 2538 0225
Consilium Strategic Communications +44 (0)20 3709 5700
Mary-Jane Elliott nexstim@consilium-comms.com
Amber Bielecka
Ivar Milligan
Laura Thornton
About Nexstim
Nexstim, formed in 2000 and based in Finland, is a medical technology company
aiming to improve rehabilitation for stroke patients. Nexstim has pioneered its
technology in brain diagnostics with the Navigated Brain Stimulation (NBS)
system as the first and only FDA-cleared and CE-marked navigated Transcranial
Magnetic Stimulation (nTMS) device for pre-surgical mapping of the motor and
speech cortices. Based on the same technology platform, the company has
developed a device for stroke therapy called Navigated Brain Therapy (NBT®). In
H1 2014, Nexstim initiated a two-year pivotal Phase III study at 12 sites in the
US aiming to demonstrate the effectiveness of NBT® and gain FDA clearance for
commercialisation in post-acute stroke therapy in the US. Nexstim's shares are
listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more
information please visit www.nexstim.com.
[HUG#1879232]